Nonmotor versus motor symptoms: How much do they matter to health status in Parkinson's disease?
- 27 September 2011
- journal article
- research article
- Published by Wiley in Movement Disorders
- Vol. 27 (2) , 236-241
- https://doi.org/10.1002/mds.23961
Abstract
Evidence suggests that both motor and nonmotor symptoms contribute to health status in Parkinson's disease. Less clear is how much change in health status can be expected if these clinical variables change. In addition, anxiety, separate from depression, has rarely been examined as a predictor of health status. We used hierarchical multiple regression analysis and standardized beta coefficients in a prevalent cohort of 462 patients with Parkinson's disease to explore the relative impact on health status (measured using the Parkinson's Disease Questionnaire) of 5 well-recognized symptom domains in Parkinson's disease: motor signs, depression, anxiety, cognition, and other nonmotor symptoms. In the health status scores, 19.6% of variance was explained by age, number of comorbidities, disease duration, and levodopa equivalent dose. Younger age predicted worse health status. A full regression model containing baseline variables and all 5 symptom domains explained 56% of the variance in health status. The standardized beta coefficient for depression was 2.1, 1.6, and 1.3 times that of motor signs, anxiety, and other nonmotor symptoms, respectively. Our findings provide a ranking order of clinical variables for their relative impact on health status in Parkinson's disease and show that depression has more than twice the impact of motor signs on health status. Anxiety and other nonmotor symptoms are also important separate determinants of poor health status in Parkinson's disease. Our results will help to guide the development of individual care and service planning for patients with Parkinson's disease. © 2011 Movement Disorder SocietyKeywords
This publication has 39 references indexed in Scilit:
- Anxious and depressive symptoms in Parkinson's disease: The French cross‐sectionnal DoPaMiP studyMovement Disorders, 2010
- A Longitudinal Evaluation of Health-Related Quality of Life of Patients with Parkinson's DiseaseValue in Health, 2009
- Quantitation of non‐motor symptoms in Parkinson’s diseaseEuropean Journal of Neurology, 2008
- Efficacy and tolerability of duloxetine in elderly patients with generalized anxiety disorder: a pooled analysis of four randomized, double‐blind, placebo‐controlled studiesHuman Psychopharmacology: Clinical and Experimental, 2008
- The minimal important difference of the hospital anxiety and depression scale in patients with chronic obstructive pulmonary diseaseHealth and Quality of Life Outcomes, 2008
- The Addenbrooke's Cognitive Examination Revised (ACE‐R): a brief cognitive test battery for dementia screeningInternational Journal of Geriatric Psychiatry, 2006
- Factors impacting on quality of life in Parkinson's disease: Results from an international surveyMovement Disorders, 2002
- The PDQ-8: Development and validation of a short-form parkinson's disease questionnairePsychology & Health, 1997
- The Hospital Anxiety and Depression ScaleActa Psychiatrica Scandinavica, 1983
- ParkinsonismNeurology, 1967